Lan-Ping Xu Selected Research

Basiliximab

1/2022	Adoptive therapy with cytomegalovirus-specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacy.
1/2020	Prognostic factors and long-term follow-up of basiliximab for steroid-refractory acute graft-versus-host disease: Updated experience from a large-scale study.
1/2020	Basiliximab as Treatment for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients after Haploidentical Hematopoietic Stem Cell Transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lan-Ping Xu Research Topics

Disease

61	Leukemia 10/2022 - 04/2006
52	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2022 - 04/2007
40	Residual Neoplasm 10/2022 - 07/2008
31	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 10/2008
28	Infections 01/2022 - 06/2004
25	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 01/2011
21	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 06/2004
16	Aplastic Anemia (Anemia, Hypoplastic) 12/2022 - 04/2004
15	Thrombocytopenia (Thrombopenia) 01/2022 - 08/2011
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 08/2008
11	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 12/2016
10	Bronchiolitis Obliterans Syndrome 01/2022 - 01/2010
9	Philadelphia Chromosome 11/2021 - 01/2011
8	Hematologic Diseases (Blood Diseases) 01/2022 - 08/2009
8	Neoplasms (Cancer) 01/2021 - 04/2007
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016 - 08/2008
6	Viremia 06/2021 - 01/2007
5	Hemorrhage 01/2022 - 01/2007
5	Cytomegalovirus Infections (Inclusion Disease) 01/2022 - 06/2007
5	Hemorrhagic Cystitis 07/2018 - 01/2007
4	Pneumonia (Pneumonitis) 10/2021 - 06/2009
3	Virus Diseases (Viral Diseases) 11/2022 - 01/2014
3	Thrombotic Microangiopathies 01/2022 - 02/2018
3	Demyelinating Diseases (Demyelinating Disease) 11/2021 - 03/2013
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2020 - 12/2007
3	Wilms Tumor (Wilm's Tumor) 11/2019 - 05/2016
3	Multiple Myeloma 08/2019 - 01/2018
2	Mycoses (Diseases, Fungus) 03/2022 - 07/2017
2	Pancytopenia 01/2022 - 03/2020
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2021 - 05/2012
2	Disease Progression 01/2021 - 01/2019
2	Melanoma (Melanoma, Malignant) 11/2019 - 08/2016
2	Cytopenia 08/2019 - 01/2018
2	Hepatitis 01/2019 - 04/2008
2	Necrosis 01/2018 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 11/2017
2	Fever (Fevers) 08/2016 - 03/2012
1	Proteinuria 12/2021
1	Anemia 12/2021
1	Epstein-Barr Virus Infections 11/2021
1	Myeloid Sarcoma (Chloroma) 03/2021

Drug/Important Bio-Agent (IBA)

18	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 05/2008
12	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 04/2004
9	Inosine Triphosphate (ITP)IBA 01/2022 - 12/2016
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 05/2011
7	InterferonsIBA 01/2022 - 11/2015
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 08/2008
5	Prostaglandins FIBA 01/2022 - 10/2015
5	AntigensIBA 11/2021 - 08/2014
5	Immunoglobulin G (IgG)IBA 11/2021 - 07/2012
5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 12/2015
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2017
4	SteroidsIBA 01/2021 - 01/2019
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 05/2008
4	LigandsIBA 12/2019 - 04/2007
3	Biological ProductsIBA 11/2022 - 05/2011
3	Basiliximab FDA Link 01/2022 - 01/2020
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 10/2017
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020 - 08/2008
3	HLA-B Antigens (HLA-B)IBA 01/2019 - 03/2012
3	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 01/2011
3	Methotrexate (Mexate)FDA LinkGeneric 07/2015 - 07/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2015 - 07/2008
2	erucylphosphocholineIBA 10/2022 - 01/2018
2	BilirubinIBA 01/2022 - 12/2021
2	Chimeric Antigen ReceptorsIBA 11/2021 - 12/2020
2	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 06/2009
2	AntibodiesIBA 11/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2016
2	GlucocorticoidsIBA 01/2019 - 07/2012
2	HLA-A Antigens (HLA-A)IBA 01/2019 - 01/2018
2	Methylprednisolone FDA LinkGeneric 01/2019 - 08/2011
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 01/2018
2	Busulfan (Busulfex)FDA Link 01/2018 - 08/2008
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2018 - 01/2018
2	C-Reactive ProteinIBA 02/2017 - 08/2016
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021

Therapy/Procedure

152	Hematopoietic Stem Cell Transplantation 12/2022 - 01/2007
63	Transplantation 12/2022 - 04/2004
36	Stem Cell Transplantation 03/2022 - 06/2012
26	Therapeutics 01/2022 - 01/2007
20	Drug Therapy (Chemotherapy) 10/2022 - 12/2007
12	Haploidentical Transplantation 01/2021 - 11/2009
7	Cell Transplantation 01/2020 - 04/2006
5	Immunotherapy 05/2021 - 08/2016
4	Induction Chemotherapy 01/2021 - 01/2016
4	Aftercare (After-Treatment) 01/2021 - 05/2011
3	Salvage Therapy 01/2021 - 10/2016
3	Consolidation Chemotherapy 03/2019 - 01/2016
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2021 - 11/2020
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2017 - 02/2009
1	Homologous Transplantation 01/2022
1	Plasma Exchange 01/2022
1	Total Parenteral Nutrition 01/2021